Glenview’s Hot Streak Continues

Health care stocks are not the only reason why Larry Robbins has delivered a double-digit gain in the first two months of the year.

Stephen Taub March 2, 2021

Larry Robbins

(Alex Flynn/Bloomberg)

Larry Robbins’ Glenview Capital is off to a very strong start this year.The health-care-driven hedge fund firm surged 9.4 percent in February, boosting its gains for the first two months to 16.3 percent, according to a person who has seen the numbers.Glenview declined to comment.The

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.12.03 build:2025-12-12 Login